Parental awareness and practices regarding paracetamol use in children: A cross-sectional study from Pakistan

Muhammad Saad Nadeem Butt1, Sana Shah2

  • 1Islam Medical College, Sialkot, Pakistan.

PLOS Global Public Health
|October 23, 2025
PubMed

Insights

Parental awareness of paracetamol (acetaminophen) usage and toxicity is critically low in Pakistan. Most parents lack sufficient knowledge, increasing the risk of paracetamol poisoning in children and necessitating educational interventions.

Area of Science:

  • Pharmacology
  • Public Health
  • Pediatrics

Background:

  • Paracetamol is a widely used analgesic and antipyretic, available over-the-counter (OTC).
  • Parental awareness regarding paracetamol usage and toxicity in children is a global concern, particularly understudied in Pakistan.
  • Medication-associated toxicity in low-resource settings poses significant public health risks.

Purpose of the Study:

  • To assess parental awareness of paracetamol usage and toxicity in Sialkot city, Pakistan.
  • To identify critical public health risks associated with improper paracetamol use in children.
  • To inform policy interventions for reducing medication-associated toxicity.

Main Methods:

  • A cross-sectional study was conducted using an Urdu-language questionnaire adapted from previous literature.
  • Data were collected from 418 parents (67% mothers) across six pediatric healthcare facilities.
  • A knowledge score was used to assess parental awareness, with insufficient knowledge defined as scoring below 66.67%.

Main Results:

  • Nearly all participants used paracetamol for fever (99%), while fewer used it for pain (18%) or general illness symptoms (81%).
  • Most parents administered paracetamol as syrup, with healthcare providers being the primary source of dosage information.
  • Only 32.8% of parents knew that paracetamol overdose could be harmful, and 75.8% demonstrated insufficient knowledge.

Conclusions:

  • A significant lack of parental knowledge regarding appropriate paracetamol use and its toxicity risks was identified in Pakistan.
  • The findings highlight a substantial risk of paracetamol poisoning due to widespread insufficient awareness.
  • Educational initiatives are crucial to improve parental knowledge, reduce toxicity risks, and enhance safe paracetamol administration in children.

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
241
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
191
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
251
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
209
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
250
Factors Affecting Drug Response: Overview01:21

Factors Affecting Drug Response: Overview

When it comes to infants and young children, they are typically administered smaller doses of medication in comparison to adults. This is primarily because their organ functions still need to fully develop, meaning their bodies are not as efficient at metabolizing or eliminating drugs. Additionally, their blood-brain barrier is more permeable than in adults. As a result, high concentrations of drugs can easily penetrate the central nervous system (CNS), potentially leading to neurological...
3.0K